Prior Academic Affiliations:
2020, M.S., Pharmacology, China Medical University, China
2017, B.S., Clinical Pharmacy, China Medical University, China
Thesis Mentor: Jianjun Chen, Ph.D.
Thesis Project:
Research/Professional Experiences:
Ph.D. student in Biopharmaceutics Science, University of the Pacific, US
Graduate Teaching Assistant, University of the pacific, US
Undergraduate Research Assistant, China Medical University, China
Pharmacy Intern, The people's hospital of Liaoning Province, China
Publications:
Niu Yan-Xin.*, Xu Zhao-Xu.*, Yu Li-Feng., Lu Yong-Ping., Wang Yan., Wu Ce., Hou Yi-Bo., Li Jia-Ning., Huang Shengqiang., Song Xinyue., Wang Xinyu., Wang Jiaqi., Li Binyu., Guo Yingrui., Yu Zhaojin., Zhao Lin., Yi Dong-Xu., Wei Min-Jie.(2022). Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy. Int Immunopharmacol, 109, 108783.
Zhao Jianhang.*, Xu Zhaoxu.*, Liu Yan., Wang Xiaobin., Liu Xinli., Gao Yanan., Jin Ying.(2022). The expression of cancer-testis antigen in ovarian cancer and the development of immunotherapy. Am J Cancer Res, 12(2), 681-694.
Xu Zhaoxu.*, Tang Haichao., Zhang Tianshu., Sun Mingli., Han Qiang., Xu Jiao., Wei Minjie., Yu Zhaojin.(2020). TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy. Life Sci, 241(undefined), 117171.
Tang Haichao.*, Liu Wensi., Xu Zhaoxu., Zhao Jianhang., Wang Weitao., Yu Zhaojin., Wei Minjie.(2021). Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration. J Cell Mol Med, 25(12), 5534-5546.